L'Università degli Studi di Verona è una università statale italiana fondata nel 1982.

During the past decade, University of Verona conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Verona" #1 sponsor was "Universita di Verona" with 20 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored, "Azienda Ospedaliera Universitaria Integrata Verona" with 1 trials sponsored and "Catholic University of the Sacred Heart" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Verona" #1 collaborator was "Universita di Verona" with 4 trials as a collaborator, "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Innovative Medicines Initiative" with 2 trials as a collaborator, "Janssen Research & Development, LLC" with 2 trials as a collaborator and "Marialuisa Gandolfi" with 2 trials as a collaborator. Other collaborators include 90 different institutions and companies that were collaborators in the rest 97 trials.

According to Clinical.Site data, the most researched conditions in "University of Verona" are "Atherosclerosis" (2 trials), "Endothelial Dysfunction" (2 trials), "Malnutrition" (2 trials), "Mixed Cancer" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "University of Verona" in a lesser frequency.

Most popular intervention types in "University of Verona" are "Other" (11 trials), "Behavioral" (8 trials), "Drug" (8 trials), "Device" (6 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Secukinumab" (2 trials), "Alectinib" (1 trials), "Aortic valve replacement" (1 trials) and "Ataluren (PTC124®)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Verona" are 36 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Verona". 2 are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in University of Verona, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Verona, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 17 trials that are defined as “Not Applicable".

University of Verona has several departments that took part in Clinical trials: "Section of Clinical Neurology, Department Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy" - 4 trials, "Policlinico G.B. Rossi; Dip. Scienze Neurologiche Biomediche - Neurologia B - Amb. Sclerosi Multipla" - 3 trials, "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia" - 3 trials, "Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona" - 2 trials, "AOUI Verona - University of Verona - Department of Obstetrics and Gynecology" - 6 trials